NCT01963338View on ClinicalTrials.gov

A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
PainVaccination Adverse Event
Interventions
DEVICE

Intradermal injection in the forearm (0,1cc NaCl 0,9%)

This injection is conducted by the newly developed device.

DEVICE

Intradermal injection in the upper arm (0,1cc NaCl 0,9%)

This injection is conducted by the newly developed device in the upper arm (deltoid region).

DRUG

Intramuscular injection in the upper arm (0,5cc NaCl 0,9%)

This injection is conducted by needle and syringe in the upper arm (deltoid region).

Trial Locations (1)

2650

University of Antwerp, Wilrijk

All Listed Sponsors
lead

Pierre Van Damme

OTHER

NCT01963338 - A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination | Biotech Hunter | Biotech Hunter